QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(Moderate)

(Very Positive)

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL) announced that its Board Compensation Committee approved an inducement grant of restricted stock units covering 356,555 shares of common stock to Chief Financial Officer and principal financial officer Micah Young. The RSUs were granted under the 2026 Inducement Plan pursuant to Nasdaq Listing Rule 5635(c)(4).

The grant date is July 15, 2026, and the RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to Mr. Young’s continued employment. The award is governed by the 2026 Inducement Plan and a related RSU agreement.

News Explained

The July 15 grant gives the CFO an award covering 356,555 common-stock shares, but vesting is spread across three anniversaries and depends on continued employment, so it is a future, conditional equity award rather than an immediate transfer of all covered shares.

News Market Reaction – QDEL

+0.05%

3 alerts

+0.05% Session close to close

+3.4% Peak Tracked

$1.22B Market Cap

0.1x Rel. Volume

In the Jul 16 session, QDEL gained 0.05%, reflecting a mild positive market reaction. Argus tracked a peak move of +3.4% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Platform data shows moderate short positioning in QuidelOrtho, suggesting some investors are positio...

Analysis

Platform data shows moderate short positioning in QuidelOrtho, suggesting some investors are positioned for volatility. Against that backdrop, this CFO-focused equity inducement is primarily governance and compensation housekeeping; key risks remain operational execution and any future financing or compensation-related dilution to monitor.

Key Figures

Inducement RSUs granted: 356,555 shares Vesting schedule: 3 annual installments

2 metrics

Inducement RSUs granted 356,555 shares Equity award to CFO under 2026 Inducement Plan

Vesting schedule 3 annual installments RSUs vest on first three anniversaries of Jul 15, 2026

Historical Context

5 past events · Latest: Jun 23 (Neutral)

5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 23	CFO appointment	Neutral	-3.5%	Announced appointment of new Chief Financial Officer effective July 6, 2026.
Jun 02	Strategic collaboration	Neutral	+0.1%	Collaboration with Allo Hope Foundation to improve education and early testing.
May 21	Educational content	Neutral	+4.0%	Released podcast episode on hemolytic disease and maternal alloimmunization awareness.
May 20	Conference participation	Neutral	+3.8%	Planned participation in June 2026 investor conferences with presentations and fireside chat.
May 05	1Q26 earnings report	Neutral	-6.0%	Reported Q1 2026 results and updated full-year 2026 revenue and EPS guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, nasdaq listing rule 5635(c)(4), inducement plan

3 terms

restricted stock units financial

"approved the grant of restricted stock units ("RSUs") with respect to 356,555"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

inducement plan financial

"granted pursuant to the Company's 2026 Inducement Plan and as an inducement"

An inducement plan is a program a company creates to encourage employees or new hires to stay or join by offering special benefits or rewards. It’s like a company giving extra bonuses or perks to persuade someone to choose their job over others, helping the company attract and keep talented workers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

07/15/2026 - 07:31 PM

SAN DIEGO, July 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of restricted stock units ("RSUs") with respect to 356,555 shares of the Company's common stock (the "Inducement Grant") to Micah Young, the Company's Chief Financial Officer and principal financial officer. The Inducement Grant was granted pursuant to the Company's 2026 Inducement Plan and as an inducement material to Mr. Young's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

The 2026 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of QuidelOrtho, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with QuidelOrtho, pursuant to Nasdaq Listing Rule 5635(c)(4).

The RSUs were granted with a grant date of July 15, 2026, and will vest in equal annual installments on the first three anniversaries of the grant date, subject to Mr. Young's continued employment with the Company through each applicable vesting date. The RSUs are subject to the terms and conditions of the 2026 Inducement Plan and the terms and conditions of a RSU award agreement covering the grant.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com

Media Contact:
Stephanie Kleewein
Senior Corporate Communication and PR Manager
media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-302826948.html

SOURCE QuidelOrtho Corporation

FAQ

What did QuidelOrtho (QDEL) announce on July 15, 2026 regarding an inducement grant?

QuidelOrtho announced an inducement grant of restricted stock units covering 356,555 shares to Chief Financial Officer Micah Young. According to QuidelOrtho, the RSUs were approved by the Board’s Compensation Committee under the 2026 Inducement Plan pursuant to Nasdaq Listing Rule 5635(c)(4).

How many RSUs did QuidelOrtho grant to CFO Micah Young and under which plan?

QuidelOrtho granted 356,555 restricted stock units to CFO and principal financial officer Micah Young. According to QuidelOrtho, the award was made under the company’s 2026 Inducement Plan as an inducement to his employment, consistent with Nasdaq Listing Rule 5635(c)(4).

What is the vesting schedule for Micah Young’s QuidelOrtho (QDEL) inducement RSUs?

The RSUs granted to Micah Young vest in three equal annual installments. According to QuidelOrtho, vesting occurs on each of the first three anniversaries of the July 15, 2026 grant date, subject to his continued employment with the company on each applicable vesting date.

What is QuidelOrtho’s 2026 Inducement Plan used for under Nasdaq Listing Rule 5635(c)(4)?

QuidelOrtho’s 2026 Inducement Plan is used exclusively for equity awards to individuals not previously employed, or after a bona fide break in service. According to QuidelOrtho, these awards serve as inducements for such individuals to enter into employment, under Nasdaq Listing Rule 5635(c)(4).

Who is the recipient of QuidelOrtho’s July 2026 inducement RSU grant and what is his role?

The inducement RSU grant was awarded to Micah Young, QuidelOrtho’s Chief Financial Officer and principal financial officer. According to QuidelOrtho, the RSU award was a material inducement to his entering into employment with the company under its 2026 Inducement Plan.